Day 2 Highlights from ASH 2024: S...

Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insights

Curie: The Oncology Brief di Curie: The Platform for HCPs

Note sull'episodio

Love what you hear? Download the Curie app from the App Store today.

Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals.

On Day 2 of ASH 2024, we explore breakthroughs in treating high-risk smoldering multiple myeloma, advancements in chronic lymphocytic leukemia therapies, and a revealing study on leukemia risk in Ground Zero first responders. Stay updated with insights that are reshaping hematology practice.

Parole chiave
podcastCancer diagnosticsHCPsDoctorsUSAASHMyelomaLeukemia